United States Thrombectomy Devices Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Thrombectomy Devices Market reached US$ 1.48 billion in 2023 and is expected to reach US$ 2.31 billion by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ In September 2025, Imperative Care, Inc. received U.S. FDA 510(k) clearance for its Symphony Thrombectomy System to treat pulmonary embolism (PE). The approval extends the device's indication from venous thrombosis to the full spectrum of venous thromboembolism, expanding treatment options in interventional cardiology.

✅ In June 2025, Inquis Medical's AVENTUS Thrombectomy System received FDA 510(k) clearance for PE treatment. The system integrates tissue-sensing technology and autologous blood reinfusion, improving precision in clot removal while minimizing blood loss.

✅ In April 2025, VentiV Scientific obtained FDA clearance for its VentiV Mechanical Thrombectomy System featuring the Pulse platform that allows adjustable tip force. The innovation reduces catheter clogging and enhances safety during large-lumen clot extraction in peripheral arteries.

Japan: Recent Industry Developments (Thrombectomy Devices)

✅ In March 2025, Inari Medical, Inc. began a post-market surveillance study of its ClotTriever Thrombectomy System (for DVT) following its earlier Japanese reimbursement approval; the study aims to evaluate real-world safety and efficacy in Japanese clinical practice.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/thrombectomy-devices-market?sb

Recent Mergers and acquisitions:

United States: Recent Mergers & Acquisitions

✅ In February 2025, Stryker Corporation completed the acquisition of Inari Medical, Inc. for approximately USD 4.9 billion in cash. The deal added Inari's venous thrombectomy platforms ClotTriever and FlowTriever to Stryker's growing endovascular and neurointerventional portfolio, reinforcing its leadership in minimally invasive clot-removal technologies.

✅ In April 2025, a leading U.S. neurovascular device manufacturer acquired a startup specializing in distal-vessel clot-retrieval thrombectomy technology. The acquisition brings proprietary microcatheter and low-profile clot-engagement innovations into the acquirer's thrombectomy device line, strengthening its stroke intervention capabilities.

✅ In January 2025, Surmodics, Inc. completed the acquisition of Vetex Medical Limited, expanding its thrombectomy portfolio with the ReVeneTM mechanical thrombectomy catheter designed for mixed-morphology clot removal. The deal enhances Surmodics' peripheral and venous intervention offerings in the U.S. market.

✅ In November 2024, Penumbra, Inc. announced a strategic investment and partial acquisition of a U.S.-based startup focused on next-generation aspiration catheters for neurovascular thrombectomy. The move aims to accelerate product innovation and expand Penumbra's access to emerging clot-extraction technologies.

Japan: Recent Mergers & Acquisitions

✅ In July 2025, Kaneka Corporation announced a strategic collaboration and minority stake acquisition in Rapid Medical Ltd., the developer of the TIGERTRIEVER device. The investment supports Kaneka's entry into Japan's neurovascular thrombectomy market and strengthens local distribution and R&D integration.

✅ In May 2025, a leading Japanese medical technology firm acquired a domestic startup specializing in microcatheter and guidewire systems for endovascular thrombectomy. The acquisition enhances Japan's capacity for in-country production and innovation in stroke and vascular intervention devices.

✅ In February 2025, Terumo Corporation entered a joint-development and technology-transfer agreement with a U.S.-based thrombectomy device company to co-create next-generation aspiration systems optimized for Asian anatomical needs. The deal expands Terumo's neurointerventional device pipeline.

Key Players:

=> Medtronic plc, Boston Scientific Corporation, Penumbra, Inc., Acandis GmbH, Stryker Corporation, Terumo Corporation, Argon Medical Devices, Teleflex Incorporated, Merit Medical Systems and phenox GmbH among others.

Growth Forecast Projected:

The Global Thrombectomy Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Thrombectomy Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=thrombectomy-devices-market

Key Segments:

➥ By Product Type: Hydrodynamic Thrombectomy Devices, Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Percutaneous Thrombectomy Devices

➥ By Application: Ischemic Stroke, Peripheral Artery Disease, Pulmonary Embolism, Deep Vein Thrombosis, Coronary Artery Disease (CAD), Others

➥ By End-User: Hospitals, Specialty Clinics, Academic and Research Institutes, Others

Regional Analysis for Thrombectomy Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Thrombectomy Devices producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Thrombectomy Devices revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/thrombectomy-devices-market?sb

FAQ

What is the current size of the Thrombectomy Devices Market?

A: In 2023, the Thrombectomy Devices Market was valued at US$ 1.48 billion, reflecting its strong industry presence.

Q2: How large is the Thrombectomy Devices Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Thrombectomy Devices Market will grow to around US$ 2.31 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Thrombectomy Devices Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.8% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.